This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt, Tech Universität München, Technical University of Munich. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 94 
1 out of 1 
1 out of 152 
Years Active: 2019
Title: Percy Knolle: Innovator in Vaccination Strategies
Introduction
Percy Knolle is a notable inventor based in Munich, Germany. He has made significant contributions to the field of vaccination strategies, particularly through his innovative approach to enhancing immune responses.
Latest Patents
Percy Knolle holds a patent for a vaccination strategy that utilizes TLR 9 and TLR 4 agonists. This invention focuses on using these agonists as multiplying jump agents to enhance the numbers and functionality of CD8 T cells in a prime-jump vaccination strategy. The strategy is particularly effective against acute and chronic infections with intracellular pathogens and for anti-tumor vaccination. Additionally, his patent includes a kit containing a prime agent and a multiplying jump agent.
Career Highlights
Throughout his career, Percy Knolle has worked with prestigious institutions such as Klinikum Rechts Der Isar der Technischen Universität München and Technische Universität München. His work has been instrumental in advancing the understanding and application of vaccination techniques.
Collaborations
Percy has collaborated with notable colleagues, including Li-Rung Huang and Mathias Heikenwälder. Their combined expertise has contributed to the development of innovative solutions in the field of immunology.
Conclusion
Percy Knolle's contributions to vaccination strategies highlight his role as an influential inventor in the medical field. His innovative approaches continue to pave the way for advancements in immunotherapy and vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile